Digital Content 
NEWS #PharmaBuzz
21 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/21/3169954/0/en/Nxera-s-Partner-Cancer-Research-UK-Presents-Data-from-Successfully-Completed-Phase-1-Clinical-Trial-of-Cancer-Immunotherapy-Drug-HTL0039732-at-ESMO.html
21 Oct 2025
// PRESS RELEASE
https://ir.exelixis.com/news-releases/news-release-details/exelixis-announces-detailed-results-phase-3-stellar-303-pivotal
20 Oct 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-10-20/genentech-s-tecentriq-showed-significant-overall-and-disease-free-survival-benefits-in-bladder-cance
20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251019498450/en/Successful-IMvigor011-Trial-Achieves-41-Improvement-in-Overall-Survival-for-Bladder-Cancer-Patients
20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251015179453/en/Exelixis-Announces-Detailed-Results-from-Phase-3-STELLAR-303-Pivotal-Trial-Evaluating-Zanzalintinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-in-Metastatic-Colorectal-Cancer-Presented-at-ESMO-2025-and-Published-in-The-Lancet
03 Oct 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-jazz-pharmas-therapy-lung-cancer-2025-10-02/
Share 